MS

Mohd Saleem

Active Director Director DIN 08640023
DIN 08640023 First appointment Dec 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2019
Shareholding value •••• Premium profile

About Mohd Saleem

Data last updated:

Mohd Saleem is a Director at Phoebus Hospital Private Limited (since 2019). The company operates in Healthcare. Phoebus Hospital Private Limited reported revenue of ₹1.85 Cr (FY 2024).

DIN 08640023
Primary Designation Director
Industry Healthcare
First Appointment 19 Dec 2019
Oldest Company Age 6 yrs
Largest company Phoebus Hospital Private Limited · ₹1.85 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Phoebus Hospital Private Limited U85110UP2019PTC124753
Director19 Dec 20192019₹1.85 Cr (FY 2024)Active

Board colleagues of Mohd Saleem

Directorship timeline

Open interactive timeline →
Phoebus Hospital Private Limited
Premium access

Shareholding and investment profile for Mohd Saleem

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohd Saleem

Mohd Saleem currently holds 1 directorship: Phoebus Hospital Private Limited (Director, since 19 Dec 2019, revenue ₹1.85 Cr (FY 2024)).

Mohd Saleem was first appointed on 19 Dec 2019 as Director at Phoebus Hospital Private Limited.

The current boards of Mohd Saleem's companies include Narendra Kumar Verma (Phoebus Hospital Private Limited), Neelabh Agrawal (Phoebus Hospital Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available